FDA approves Syndax’s Revuforj for acute leukemia
The Food and Drug Administration approved Revuforj from Syndax (SNDX) Pharmaceuticals, a menin inhibitor, for relapsed or refractory acute ...
US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
New FDA rules for TV drug ads: Plain language and no distractions
The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...
Cheat sheet: How RFK Jr., Trump's pick for HHS secretary, promises to 'Make America Healthy Again'
Robert F. Kennedy Jr. has promised to "make America healthy again." What does that actually mean? Here's everything he ...
Business Insider4d
Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer
BEDFORD, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to improving vision in the real world through ...